← Evidence map

ArticleVaccines2023

Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage.

Jidapa Szekely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37515045